These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gut-derived sepsis with Pseudomonas aeruginosa. Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K Cytokine; 1999 May; 11(5):366-72. PubMed ID: 10328876 [TBL] [Abstract][Full Text] [Related]
7. Effect of passive immunotherapy on murine gut-derived sepsis caused by Pseudomonas aeruginosa. Matsumoto T; Furuya N; Tateda K; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K J Med Microbiol; 1999 Aug; 48(8):765-770. PubMed ID: 10451000 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-1-deficient mice exhibit high sensitivity to gut-derived sepsis caused by Pseudomonas aeruginosa. Horino T; Matsumoto T; Uramatsu M; Tanabe M; Tateda K; Miyazaki S; Nakane A; Iwakura Y; Yamaguchi K Cytokine; 2005 Jun; 30(6):339-46. PubMed ID: 15935954 [TBL] [Abstract][Full Text] [Related]
9. Effects of a human antiflagellar monoclonal antibody in combination with antibiotics on Pseudomonas aeruginosa infection. Uezumi I; Terashima M; Kohzuki T; Kato M; Irie K; Ochi H; Noguchi H Antimicrob Agents Chemother; 1992 Jun; 36(6):1290-5. PubMed ID: 1416830 [TBL] [Abstract][Full Text] [Related]
10. Effect of interleukin-10 on gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K Antimicrob Agents Chemother; 1998 Nov; 42(11):2853-7. PubMed ID: 9797215 [TBL] [Abstract][Full Text] [Related]
11. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231 [TBL] [Abstract][Full Text] [Related]
12. Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum. Drake D; Montie TC Can J Microbiol; 1987 Sep; 33(9):755-63. PubMed ID: 3121159 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia. Oishi K; Sonoda F; Iwagaki A; Ponglertnapagorn P; Watanabe K; Nagatake T; Siadak A; Pollack M; Matsumoto K Antimicrob Agents Chemother; 1993 Feb; 37(2):164-70. PubMed ID: 8383936 [TBL] [Abstract][Full Text] [Related]
14. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice. O'Oka H; Chonan E; Mizutani K; Fukuda T; Kuroiwa Y; Ono Y; Shigeta S Microbiol Immunol; 1992; 36(12):1305-16. PubMed ID: 1287405 [TBL] [Abstract][Full Text] [Related]
15. [Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia]. Vetkova LG; Zaĭtsev LG; Khasman EL; Radkevich SA; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):14-8. PubMed ID: 3085409 [TBL] [Abstract][Full Text] [Related]
16. Prevention of siderophore- mediated gut-derived sepsis due to P. aeruginosa can be achieved without iron provision by maintaining local phosphate abundance: role of pH. Romanowski K; Zaborin A; Fernandez H; Poroyko V; Valuckaite V; Gerdes S; Liu DC; Zaborina OY; Alverdy JC BMC Microbiol; 2011 Sep; 11():212. PubMed ID: 21943078 [TBL] [Abstract][Full Text] [Related]
17. Systemic and topical protection studies using Pseudomonas aeruginosa flagella in an ocular model of infection. Rudner XL; Hazlett LD; Berk RS Curr Eye Res; 1992 Aug; 11(8):727-38. PubMed ID: 1424719 [TBL] [Abstract][Full Text] [Related]
18. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis. Faezi S; Sattari M; Mahdavi M; Roudkenar MH Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822 [TBL] [Abstract][Full Text] [Related]
19. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577 [TBL] [Abstract][Full Text] [Related]